Oral

Study: Nicotinamide Riboside for Patients With Early-Stage Parkinson Disease. Image Credit: Fabian Montano Hernandez / Shutterstock

October 13, 2026

Encouraging results from earlier studies prompted researchers to investigate whether an NAD-boosting supplement could improve Parkinson’s symptoms during…

HHealth

Severe long Covid associated with distinct oral and lung microbiomes

October 12, 2026

A study of more than 700 people has shown that those with long Covid have distinct differences in…

HHealth

New diabetes pill orforglipron achieves uniform weight loss for women of all ages

September 28, 2026

New analyses to be presented at the Annual Meeting of The European Association for the Study of Diabetes…

HHealth

MD Anderson researchers showcase new findings in radiation oncology at ASTRO 2026

September 26, 2026

Experts from The University of Texas MD Anderson Cancer Center will present nearly 70 abstracts at the 2026…

HHealth

Study: Beyond medication adherence: bisphenol exposure and its relationship with good glycemic control in type 2 diabetes. Image Credit: Konektus Photo

September 24, 2026

Researchers measured bisphenol exposure alongside diet and medication adherence in adults with type 2 diabetes, uncovering a more…

HHealth

EVITA clinical trial evaluates oral vitamin C for pre-cancerous blood disorders

September 21, 2026

Vitamin C boosts the activity of cellular proteins called TET enzymes that help control which genes are turned…

TTechnology

Early B-cell therapy linked to better MS disease control

September 10, 2026

For people recently diagnosed with multiple sclerosis (MS), early treatment choices were associated with only slight differences after…

HHealth

Potent antiplatelet therapy increases bleeding risk after heart attack in AF patients

August 29, 2026

Potent antiplatelet therapy increased bleeding without signs of benefit regarding cardiovascular events in patients with atrial fibrillation after…

HHealth

POET-II trial reduces antibiotic duration for infective endocarditis by two weeks

August 28, 2026

A response-tailored strategy reduced antibiotic duration by two weeks without compromising the safety of patients with left-sided infective…

NNutrition

Whey protein pricing: An insider’s view on business strategy

August 19, 2026

Whey protein has far outpaced the rest of the protein category thanks to its excellent amino acid profile…

HHealth

Unlocking the secrets of oral bacteria to fight tooth decay

August 6, 2026

Some 33 million Americans have severe food allergies. Now, researchers at Boston Children’s Hospital may have found a…

HHealth

tudy: Efficacy of Silver Diamine Fluoride on Young Children With Severe Early Childhood Caries. Image Credit: Alex Mit / Shutterstock

August 4, 2026

A large US trial reveals how a quick, noninvasive dental treatment could help manage aggressive tooth decay in…

Year-long trial finds NAD-boosting supplement fails to improve early Parkinson’s symptoms

Severe long Covid associated with distinct oral and lung microbiomes

New diabetes pill orforglipron achieves uniform weight loss for women of all ages

MD Anderson researchers showcase new findings in radiation oncology at ASTRO 2026

A chemical used in BPA-free products may have a connection to diabetes control

EVITA clinical trial evaluates oral vitamin C for pre-cancerous blood disorders

Early B-cell therapy linked to better MS disease control

Potent antiplatelet therapy increases bleeding risk after heart attack in AF patients

POET-II trial reduces antibiotic duration for infective endocarditis by two weeks

Whey protein pricing: An insider’s view on business strategy

Microbiome-based therapy may increase peanut allergy tolerance in adults

Large US trial supports silver diamine fluoride for severe early childhood caries